Table 1 Timetable for study of anti-leukemia activity of sesamolin in vivo
From: Therapeutic effects of sesamolin on leukemia induced by WEHI-3B in model mice
Day | Action |
|---|---|
0 | IP injection of 1 × 105 or 1 × 106 WEHI-3B cells |
5–10 | Leukemia induction confirmed by direct peripheral blood and bone marrow smear |
10–30 | Sesamolin therapy (3 doses/week) |
31 | Sacrifice and autopsy |